These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 9398022)
61. [Delayed recurrence of an endobiliary hepatocellular carcinoma without detectable intra-parenchymatous tumor]. Vibert E; Chatelain D; Barrucand C; Garavito R; Yzet T; Delcenserie R; Mauvais F; Riboulot M; Capron JP; Dupas JL; Regimbeau JM Gastroenterol Clin Biol; 2006 May; 30(5):790-3. PubMed ID: 16801906 [TBL] [Abstract][Full Text] [Related]
62. Time to update radiological criteria for non-invasive diagnosis of hepatocellular carcinoma. Saini S; Pratt DS Hepatol Int; 2015 Jan; 9(1):1-2. PubMed ID: 25788371 [No Abstract] [Full Text] [Related]
63. Can hepatocellular carcinoma recurrence be prevented after liver transplantation? Kim JM Clin Mol Hepatol; 2021 Oct; 27(4):562-563. PubMed ID: 34551504 [No Abstract] [Full Text] [Related]
64. [Clinicopathological studies on patients with hepatocellular carcinoma. I. Selection of parameters for forecasting the prognosis (author's transl)]. Nishioka M; Fukumoto Y; Kan D; Nawata J; Takemoto T; Fukuda T; Miyaji T Rinsho Byori; 1979 Jun; 27(6):515-8. PubMed ID: 224225 [No Abstract] [Full Text] [Related]
69. Predictive models for recurrence risk of hepatocellular carcinoma after liver transplantation: Still an unmet need. Piñero F; Carrihlo FJ; Silva MO Liver Int; 2017 May; 37(5):648-650. PubMed ID: 28453922 [No Abstract] [Full Text] [Related]
70. Prognostication in hepatocellular carcinoma: is it a burden or a ticket? Tsilimigras DI; Pawlik TM Br J Surg; 2021 Apr; 108(4):337-339. PubMed ID: 33734326 [No Abstract] [Full Text] [Related]
71. [Basic principles and medical responsibilities in tumor after-care]. Ebeling K; Bodek B Z Arztl Fortbild (Jena); 1981 Jun; 75(11-12):534-40. PubMed ID: 6171108 [No Abstract] [Full Text] [Related]
74. Letter: mechanistic target of rapamycin inhibitors-do they impact on recurrence of hepatocellular carcinoma after liver transplantation? Cholongitas E Aliment Pharmacol Ther; 2019 Jul; 50(1):116-117. PubMed ID: 31184384 [No Abstract] [Full Text] [Related]
75. [Serological research in diagnosing hepatocellular carcinoma]. Liu L; Yang DH; Tang SH Zhonghua Gan Zang Bing Za Zhi; 2008 Nov; 16(11):875-7. PubMed ID: 19032880 [No Abstract] [Full Text] [Related]
76. Mammalian Target of Rapamycin Inhibitors Against Hepatocellular Carcinoma Recurrence After Liver Transplantation. Cholongitas E Transplantation; 2016 Aug; 100(8):e43-4. PubMed ID: 27306530 [No Abstract] [Full Text] [Related]
77. Direct-acting antivirals and recurrence of hepatocellular carcinoma. Marrero JA; Singal AG Liver Transpl; 2017 Sep; 23(9):1099-1100. PubMed ID: 28722785 [No Abstract] [Full Text] [Related]
78. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. ; J Hepatol; 2015 Jul; 63(1):237-64. PubMed ID: 25911335 [No Abstract] [Full Text] [Related]